Save the Date

Meet & Match: Strategies for Drug Discovery: Simulation – Screening – Repurposing

Date
Venue
Strasbourg, France
Registration deadline
Costs
free
Address
Hilton Strasbourg Hotel
1 Avenue Herrenschmidt
F-67000 Strasbourg
Type
Meet & Match
Target group
Biotech companies, contract research organisations and academic labs
Organiser
BIOPRO Baden-Württemberg GmbH und Alsace BioValley
Contact
Caroline Ref
E-mail: ref(at)bio-pro.de
Language
English
Links
Registration: Meet & Match | Strategies for Drug Discovery

Glossary

  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

Glossary

  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

Glossary

  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

Glossary

  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

The French cluster Alsace BioValley and BIOPRO Baden-Württemberg will hold their 14th Meet & Match event on 27th November in Strasbourg on the topic of strategies for drug discovery and drug development.

The event will cover a wide range of areas – from simulation, screening and target identification technologies to the repurposing of already known active ingredients / drugs.

The Meet & Match takes place the day before the partnering event BioFit.

Company representatives and project leaders from the health industry as well as academic researchers from both sides of the Rhine – France (Grand Est region) and Germany (Baden-Württemberg) – meet each other to generate new impulses or partnerships for joint developments. This event will be a great opportunity for biotech companies, contract research organisations and academic labs to present and envision future approaches, which would match the pharma industry.

To intensify the networking between the attendees they will have the possibility to present their company or research group in a two-minute-presentation prior to the networking coffee in the short presentation session. The number of partcipants in this session is limited and arranged for producing, researching and developing companies and research institutions. If you want to participate in the Short Presentation Session, apply therefore in your registration until 6th November, 2017.

The participation in the event is free of charge. The presentations will be held in English.

Preprogram

11.30 am Registration and lunch
01.00 pm Words of welcome
  PRESENTATIONS
  Dr. Vincent Mikol, Sanofi | France
  Drug Discovery Strategies
  Dr. Arnaud Sinan Karaboga, Harmonic Pharma | France
  Pharmacological Rediscovery© to identify novel clinical uses of existing safe drugs
  Dr. Horst Flotow, Hit Discovery Constance (HDC) GmbH | Germany
  HCS for drug discovery, the HDC advantage
  Dr. Mona Boyé, Ksilink | France
  Patient based Phenotypic Screening for Drug Discovery
  Prof. Dr. Ute Schepers, vasQlab | Germany
  Body on chip systems for save drug testing
  SHORT PRESENTATION SESSION
03.30 pm Networking coffee
  PRESENTATIONS
  Dr. Tania Sorg, Mouse Clinical Institute (MCI) | France
  Phenomin-ICS, an infrastructure for translational research and functional genomics
  Prof. Dr. Michael Boutros, German Cancer Research Center (DKFZ) and Heidelberg University | Germany
  High-content imaging and image analysis for drug discovery and repositioning
  Alain Xayaphoummine, Bionext | France
  Drug discovery and Repurposing: Tell me more about the targets
  Dr. Oliver Pötz, SIGNATOPE GmbH | Germany
  Monkey, Dog, Rat and Men – Drug safety biomarker across species
05.30 pm  Networking drink

 

To register for the event and for the short presentation session please follow the above mentioned link.

Glossary

  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

Glossary

  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

Glossary

  • The genome is entire genetic material of an organism. Each cell of an organism contains the entire genetic material in its nucleus.
  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Polyehylene (abbrevation: PE) is the polymer of ethylene. It belongs to the thermoplastic synthetics.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.

Glossary

  • The genome is entire genetic material of an organism. Each cell of an organism contains the entire genetic material in its nucleus.
  • Being lytic is the feature of a bacteriophage leading to the destruction (lysis) of the host cell upon infection.
  • Screening is a systematic test procedure that is used to identify certain characteristics within an array of samples or persons. In molecular biology screening is used to filter a designated clone out of a gen bank, for example.
  • Polyehylene (abbrevation: PE) is the polymer of ethylene. It belongs to the thermoplastic synthetics.
  • Biomolecules which can bind active agents are called targets. They can be receptors, enzymes or ion channels. If agent and target interact with each other the term agent-target-specific effect is used. The identification of targets is very important in biomedical and pharmaceutical research because a specific interaction can help to understand basic biomolecular processes. This is essential to identify new points of application.
Website address: https://www.bio-pro.de/en/events/drugdiscovery/